Notably, despite its anti-angiogenic role in ECs, elevated VASH1 expression in tumor blood vessels has been associated with poorer oncological prognosis and increased tumor recurrence, suggesting a complex role in tumor progression [12–16]. This evidence concerns the gene VASH1 and neoplasm.